Gaush Meditech

Gaush Meditech EBIT Margin

The EBIT Margin (Operating Margin) of Gaush Meditech (2407.HK) as of Nov 2, 2026 is 8.81 %. In the previous year, EBIT Margin (Operating Margin) was 13.80 % — a change of -36.16% (lower).

EBIT Margin

8.81 %

YoY

-36.16%

Last updated:

EBIT Margin (Operating Margin) of Gaush Meditech is 2025 8.81 % . EBIT Margin (Operating Margin) of Gaush Meditech was 2024 13.80 % . It decreases by -36.16% lower compared to the previous year.

Gaush Meditech's operating (EBIT) margin stands at 8.8%, down from 19.8% several years earlier.

The Gaush Meditech EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
16.06 CNY
Jan 1, 2020
18.93 CNY
Jan 1, 2021
19.81 CNY
Jan 1, 2022
19.64 CNY
Jan 1, 2023
19.85 CNY
Jan 1, 2024
13.80 CNY
Jan 1, 2025
8.81 CNY
The Gaush Meditech EBIT Margin history
YEAREBIT MarginYoY
8.81 %-36.16%
13.80 %-30.46%
19.85 %+1.08%
19.64 %-0.84%
19.81 %+4.62%
18.93 %+17.87%
16.06 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Gaush Meditech Stock analysis

What does Gaush Meditech do? Gaush Meditech Ltd. generates revenue through four business segments. The Proprietary Products segment develops and sells surgical equipment, intraocular lenses, and diagnostic and treatment devices for ophthalmic diseases, along with related software and consumables. The Distribution segment distributes branded ophthalmic medical devices and consumables. The Technical Services segment offers after-sales services including warranty, maintenance, and consumables support. The Others segment handles equipment leasing and intellectual property agency services. Products are used in treating conditions like cataracts, glaucoma, and pediatric ophthalmology across various medical specialties. The company's primary customers include hospitals, clinics, and medical institutions specializing in ophthalmology. These institutions purchase proprietary devices, branded consumables, and technical support services. The firm's focus on ophthalmic subspecialties ensures consistent demand for its products and services in the treatment of eye diseases. Revenue streams are diversified across product development, distribution, and post-sale services. The proprietary segment drives innovation with surgical equipment and lenses, while distribution and technical services provide steady income from established medical partners. Equipment leasing and IP services in the Others segment contribute to additional revenue without requiring direct product sales. Gaush Meditech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Gaush Meditech stock

EBIT Margin (Operating Margin) of Gaush Meditech is 8.81 % in 2025.

EBIT Margin (Operating Margin) of Gaush Meditech changed from 13.80 % to 8.81 %, representing a -36.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Gaush Meditech since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Gaush Meditech with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Gaush Meditech

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Gaush Meditech